Principal Investigator
Chryso Katsoufis
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230144
Clinical Trial Summary
A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 6 Years of Age with Hyperkalaemia (EMERALD 2)
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Nephrology
Contact Information
Study Contact
Grace Alvarez
Phone Number
+1 (305) 2434447
Email
galvarez2@miami.edu